Markets:

Overview

News

Currencies

International

Treasuries

State Street SPDR S&P Biotech ETF (NY:XBI)

151.44 -0.79 (-0.52%)

Streaming Delayed Price Updated: 10:21 AM EDT, Jul 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about State Street SPDR S&P Biotech ETF

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Biotechnology And Healthcare, A Bit Of A Lull ↗

March 25, 2024

Strong momentum of Tech and Chip stocks may be too good of a distraction for biotech investors.

Via Talk Markets

3 Biotech ETFs Overdue for a Bounce ↗

March 19, 2024

The biotech ETFs have been under serious pressure in recent years. Newfound momentum and looming lower rates could spark a comeback.

Via InvestorPlace

Topics ETFs

It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility ↗

March 11, 2024

Biotech is in a bull market aș measured by 2023 trends with a double testing of lows on 11/23.

Via Talk Markets

Are We Listening To The Market's Message? ↗

March 08, 2024

This week's video features chart/fact-based Q & A covering major stock market indexes, ETFs, the economy, homebuilders, regional banks, semiconductors, value stocks, energy stocks, biotech, and more.

Via Talk Markets

Topics ETFs Economy

“Advance Is Advancing” Stock Market (And Sentiment Results)… ↗

February 29, 2024

Commentary on the stock market, economy, inflation, biotech, and auto sales, as well as a deep dive into Advance Auto Parts.

Via Talk Markets

Topics Economy

Biotech Stocks Surge To Start 2024: 'Charts Look Great,' But Will The Trend Continue? ↗

February 28, 2024

The biotech sector has been surging in recent months, reawakening from a period of underperformance that followed the highs of 2021. David Prince, professional trader at T3 Trading Group, joined...

Via Benzinga

TG Therapeutics Soars On In-Line Report; Is The Biotech Rally Buoying Shares? ↗

February 28, 2024

The company reported in-line sales for the fourth quarter, but shares soared by double digits.

Via Investor's Business Daily

Opportunities For Investors Beyond AI And Nvidia – Biotech Breaks Out, New GDP Data Shows Inflation Pressure ↗

February 28, 2024

To gain an edge, this is what you need to know today.

Via Benzinga

Topics Artificial Intelligence Economy

ETF Theme: Range-Bound ↗

February 25, 2024

Here is the fund for the emerging markets, which is not only range-bound but seems to be following a regular time pattern.

Via Talk Markets

Topics ETFs

Healthcare Stocks Are Looking Better But What About Biotech? ↗

February 20, 2024

Large cap biopharmacuiticals remain a core holding for growth and value despite political cross-currents on drug pricing.

Via Talk Markets

Favoring IWM, XBI, And KRE ↗

February 18, 2024

It's time to employ ratios. Just like I utilize sector ratios such as XLF to XLU, XLY to XLP, or SPY to TLT, this is the time to look at IWM in comparison to the SPY.

Via Talk Markets

Sunday ETF Review, Feb. 4, 2024 ↗

February 04, 2024

Examining my

Via Talk Markets

Topics ETFs

Biotech And Medtech Portfolio Notes On A Fed Day ↗

January 31, 2024

The Fed held rates keeping their future options flexible with no expectations for future cuts. The market did not like it and sold off with the Russell 2000 down 2.45% and the NASDAQ down 2.23%

Via Talk Markets

Topics Economy

3 Biotech Stocks with Potential for Major Medical Breakthroughs in 2024 ↗

January 26, 2024

There are several potential biotech breakthroughs likely to occur in 2024, and these three biotech stocks could see substantial gains

Via InvestorPlace

Momentum Shifts Back To Tech Stocks As Healthcare Lags In 2024 ↗

January 22, 2024

Small Cap traders are taking a break in 2024 as XBI is down 2.51% YTD.

Via Talk Markets

Biotech Playbook: Small Caps Show Momentum Peaking During ↗

January 15, 2024

The momentum of selected stocks was strong up until early January was encouraging but we need less volatility in period ahead to conform a new bull market.

Via Talk Markets

5 Biotech Stocks That Should Be On Investors' Radar As JPMorgan Healthcare Conference Gets Underway Monday ↗

January 08, 2024

The rebound by biopharma stocks in 2023 and the pickup in M&A news flow makes the 2024 JPMorgan Healthcare conference even more interesting.

Via Benzinga

Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024 ↗

January 05, 2024

Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain.

Via Investor's Business Daily

2023 in Review: Key Stock Trends and Sector Shifts Unveiled ↗

January 05, 2024

Investors would be smart to pay attention to these stock trends, many of which are taking hold as the New Year begins.

Via InvestorPlace

Satori Fund's Dan Niles Names Amazon, Meta Top Stocks To Own In 2024 ↗

January 03, 2024

Satori Fund founder and portfolio manager Dan Niles is out with his top stock picks for 2024 and two Magnificent 7 names are at the top of the list.

Via Benzinga

Wall Street Thinks These 2 Biotech Stocks Could Soar in 2024 ↗

January 03, 2024

These two biotech stocks sport notable 12-month price targets. However, they are also uber-risky.

Via The Motley Fool

3 Thematic Growth ETFs to Load Up on Right Now ↗

December 30, 2023

These three thematic ETFs could be potent growth vehicles in years to come.

Via The Motley Fool

Topics ETFs

Small Caps Are On A Tear Including Speculative Biotechs ↗

December 26, 2023

So far 2023 is going well with our game plan -an end-of-year seasonal rally coupled with a run in speculative biotechs driven by innovation.

Via Talk Markets

US Stocks Eye 7-Day Winning Streak As Mortgage Rates Fall Below 7%, Yields Tumble: What's Driving Markets Thursday? ↗

December 14, 2023

It’s shaping up to be a positive Thursday on Wall Street, with risk sentiment remaining robust after the Federal Reserve effectively opened the door to rate cuts in 2024.

Via Benzinga

Topics Economy

Stocks Hold Steady, Yields Decline As Fed Meeting Looms: What's Driving Markets Wednesday? ↗

December 13, 2023

Midway through the trading day on Wall Street, calm reigns supreme as investors eagerly await the Federal Reserve’s decision on interest rates.

Via Benzinga

Topics Economy

Are These Biotechs Ready To Launch? ↗

December 09, 2023

Biotech stocks are still in the process of repairing the damage from recent months — and recent years. Indeed, as of a month ago, the SPDR Biotech Fund had been dead money for an unbelievable eight and...

Via Talk Markets

Can Small Cap Biotech Stocks Continue To Run? Let’s Take A Look ↗

December 05, 2023

Over the past 4 weeks, we have seen a nice run in small-cap, speculative biotech stocks. This coincided with the pause in interest rates and expectations of the seasonal year-end rally.

Via Talk Markets

Fed Rate Cut Speculations Rattle Stocks, Commodities Slide, Bitcoin Shines: What's Driving Markets Monday? ↗

December 04, 2023

Stocks opened the first week of December with significant losses, driven by some emerging concerns of exaggerated rate cut speculations within the trading community.

Via Benzinga

Topics Economy

Stocks, Gold, Bonds Rally Further, Dollars Tumbles As Traders Anticipate Fed Cuts: What's Driving Markets Friday? ↗

December 01, 2023

Kicking off the new month, Wall Street continued its strong November momentum, with major U.S. stocks rallying on Friday.

Via Benzinga

Topics Economy

S&P 500, Nasdaq Slip As Tech Underperforms, Oil Reacts to OPEC+: What's Driving Markets Thursday? ↗

November 30, 2023

Thursday’s trading session on Wall Street presents a mixed picture, characterized by notable fluctuations in major indices. While tech-heavy benchmarks like the S&P 500 and the Nasdaq 100 are...

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.